Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan O'Brien

Showing results (51-60 of 643) with videos related to

Pageof 65
Sort By:
American Journal of Hematology|October 16, 2012
Aspergillus pseudomembranous necrotizing tracheitisXiuning Le, Preetesh Jain, Susan O'Brien
Journal of the American Animal Hospital Association|March 29, 2013
Treatment of E. boehmi infection in a mixed-breed dog using milbemycin oximeGary Conboy, Tonya Stewart, Susan O'Brien
Clinical Lymphoma, Myeloma & Leukemia|September 24, 2023
Treatment Patterns and Outcomes in U.S. Military Veterans Diagnosed With Chronic Lymphocytic Leukemia (CLL)Helen Ma, Susan O'Brien, Pankaj Gupta
Blood|September 21, 2004
Discontinuation of imatinib therapy after achieving a molecular responseJorge Cortes, Susan O'Brien, Hagop Kantarjian
Cancer Journal (Sudbury, Mass.)|September 26, 2012
Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease?Fabio P S Santos, Susan O'Brien
Seminars in Oncology|February 1, 2017
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
Clinical Lymphoma, Myeloma & Leukemia|June 25, 2013
Homoharringtonine/omacetaxine mepesuccinate: the long and winding road to food and drug administration approvalHagop M Kantarjian, Susan O'Brien, Jorge Cortes
Current Molecular Medicine|November 25, 2005
Monoclonal antibodies in the treatment of leukemiaSusan O'Brien, Maher Albitar, Francis J Giles
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Investigational immunotherapeutics for B-cell malignanciesAlfonso Quintás-Cardama, William Wierda, Susan O'Brien
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2012
10 years of progress in chronic myelogenous leukemiaElias Jabbour, Michael S Mathisen, Susan O'Brien
Pageof 65

Showing results (51-60 of 643) with videos related to

Sort By:
Pageof 65
American Journal of Hematology|October 16, 2012
Aspergillus pseudomembranous necrotizing tracheitisXiuning Le, Preetesh Jain, Susan O'Brien
Journal of the American Animal Hospital Association|March 29, 2013
Treatment of E. boehmi infection in a mixed-breed dog using milbemycin oximeGary Conboy, Tonya Stewart, Susan O'Brien
Clinical Lymphoma, Myeloma & Leukemia|September 24, 2023
Treatment Patterns and Outcomes in U.S. Military Veterans Diagnosed With Chronic Lymphocytic Leukemia (CLL)Helen Ma, Susan O'Brien, Pankaj Gupta
Blood|September 21, 2004
Discontinuation of imatinib therapy after achieving a molecular responseJorge Cortes, Susan O'Brien, Hagop Kantarjian
Cancer Journal (Sudbury, Mass.)|September 26, 2012
Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease?Fabio P S Santos, Susan O'Brien
Seminars in Oncology|February 1, 2017
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
Clinical Lymphoma, Myeloma & Leukemia|June 25, 2013
Homoharringtonine/omacetaxine mepesuccinate: the long and winding road to food and drug administration approvalHagop M Kantarjian, Susan O'Brien, Jorge Cortes
Current Molecular Medicine|November 25, 2005
Monoclonal antibodies in the treatment of leukemiaSusan O'Brien, Maher Albitar, Francis J Giles
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Investigational immunotherapeutics for B-cell malignanciesAlfonso Quintás-Cardama, William Wierda, Susan O'Brien
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2012
10 years of progress in chronic myelogenous leukemiaElias Jabbour, Michael S Mathisen, Susan O'Brien
Pageof 65